Trial
NCT03697239
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
Phase IWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
Hitendra Patel
Collaborators
Cancer Research UK; Stand Up To Cancer; Lustgarten Foundation; Destroy Pancreatic Cancer; Translational Genomics Research Institute; HonorHealth Research Institute
Condition
Metastatic Pancreatic Cancer
Intervention
Ascorbic Acid
Why stopped
FDA indicated the same study could not be conducted under multiple INDs
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-11